Skip to main content

Table 1 Lipid, acute phase reactans and myeloperoxidase concentrations in FH patients and controls

From: Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia

 

FH (n = 8)

Controls (n = 8)

* p-value

Total Cholesterol (mg/dl)

343.1 ± 41.6

214.5 ± 32.0

< 0.001

Triglycerides (mg/dl)

196.1 ± 172.7

82.5 ± 41.4

ns

High Density Lipoprotein (mg/dl)

50.9 ± 12.0

53.6 ± 10.5

ns

Low Density Lipoprotein (mg/dl)

253.0 ± 47.7

144.4 ± 23.9

< 0.001

C Reactive Protein (mg/dl)

0.12 ± 0.08

0.08 ± 0.06

ns

C3c complement fraction (mg/dl)

135.6 ± 22.1

92.6 ± 11.3

< 0.001

C4 complement fraction (mg/dl)

31.4 ± 15.7

19.6 ± 5.5

ns

Haptoglobin (mg/dl)

114.6 ± 58.8

62.6 ± 26.5

< 0.05

α1-Antitrypsin (mg/dl)

151.7 ± 27.0

89.4 ± 12.3

< 0.001

α2-Macroglobulin (mg/dl)

183. ± 68.9

130.2 ± 31.5

< 0.05

α1-acid Glycoprotein (mg/dl)

81.5 ± 12.7

50.9 ± 4.7

< 0.0001

Ceruloplasmin (mg/dl)

24.2 ± 3.1

23.5 ± 6.7

ns

Myeloperoxidase (ng/dl)

20.4 ± 3.3

1.9 ± 1.5

< 0.01

  1. Values are mean ± SE, *parametric paired t-test.